68 related articles for article (PubMed ID: 9657374)
1. An NMR-based identification of peptide fragments mimicking the interactions of the cathepsin B propeptide.
Yu Y; Vranken W; Goudreau N; de Miguel E; Magny MC; Mort JS; Dupras R; Storer AC; Ni F
FEBS Lett; 1998 Jun; 429(1):9-16. PubMed ID: 9657374
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cathepsin B by its propeptide: use of overlapping peptides to identify a critical segment.
Chagas JR; Ferrer-Di Martino M; Gauthier F; Lalmanach G
FEBS Lett; 1996 Sep; 392(3):233-6. PubMed ID: 8774851
[TBL] [Abstract][Full Text] [Related]
3. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide.
Turk D; Podobnik M; Kuhelj R; Dolinar M; Turk V
FEBS Lett; 1996 Apr; 384(3):211-4. PubMed ID: 8617355
[TBL] [Abstract][Full Text] [Related]
5. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide.
Quraishi O; Nägler DK; Fox T; Sivaraman J; Cygler M; Mort JS; Storer AC
Biochemistry; 1999 Apr; 38(16):5017-23. PubMed ID: 10213604
[TBL] [Abstract][Full Text] [Related]
6. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
Azaryan AV; Hook VY
Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
[TBL] [Abstract][Full Text] [Related]
7. Delineating functionally important regions and residues in the cathepsin B propeptide for inhibitory activity.
Chen Y; Plouffe C; Ménard R; Storer AC
FEBS Lett; 1996 Sep; 393(1):24-6. PubMed ID: 8804416
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of human procathepsin K.
LaLonde JM; Zhao B; Janson CA; D'Alessio KJ; McQueney MS; Orsini MJ; Debouck CM; Smith WW
Biochemistry; 1999 Jan; 38(3):862-9. PubMed ID: 9893980
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity and structural characterization of a C-terminal peptide fragment derived from the prosegment of the proprotein convertase PC7.
Bhattacharjya S; Xu P; Zhong M; Chrétien M; Seidah NG; Ni F
Biochemistry; 2000 Mar; 39(11):2868-77. PubMed ID: 10715106
[TBL] [Abstract][Full Text] [Related]
10. Leishmania major: comparison of the cathepsin L- and B-like cysteine protease genes with those of other trypanosomatids.
Sakanari JA; Nadler SA; Chan VJ; Engel JC; Leptak C; Bouvier J
Exp Parasitol; 1997 Jan; 85(1):63-76. PubMed ID: 9024203
[TBL] [Abstract][Full Text] [Related]
11. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
[TBL] [Abstract][Full Text] [Related]
12. Sequential proton NMR resonance assignments, circular dichroism, and structural properties of a 50-residue substrate-binding peptide from DNA polymerase I.
Mullen GP; Vaughn JB; Mildvan AS
Arch Biochem Biophys; 1993 Feb; 301(1):174-83. PubMed ID: 8442659
[TBL] [Abstract][Full Text] [Related]
13. Selective cleavage of peptide bonds by cathepsins L and B from rat liver.
Towatari T; Katunuma N
J Biochem; 1983 Apr; 93(4):1119-28. PubMed ID: 6345516
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.
Sivaraman J; Nägler DK; Zhang R; Ménard R; Cygler M
J Mol Biol; 2000 Jan; 295(4):939-51. PubMed ID: 10656802
[TBL] [Abstract][Full Text] [Related]
15. Fasciola hepatica: characterization and cloning of the major cathepsin B protease secreted by newly excysted juvenile liver fluke.
Wilson LR; Good RT; Panaccio M; Wijffels GL; Sandeman RM; Spithill TW
Exp Parasitol; 1998 Feb; 88(2):85-94. PubMed ID: 9538862
[TBL] [Abstract][Full Text] [Related]
16. Potent slow-binding inhibition of cathepsin B by its propeptide.
Fox T; de Miguel E; Mort JS; Storer AC
Biochemistry; 1992 Dec; 31(50):12571-6. PubMed ID: 1472493
[TBL] [Abstract][Full Text] [Related]
17. Foldase and inhibitor functionalities of the pepsinogen prosegment are encoded within discrete segments of the 44 residue domain.
Dee DR; Myers B; Yada RY
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1300-6. PubMed ID: 26003941
[TBL] [Abstract][Full Text] [Related]
18. Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes.
Linnevers C; Smeekens SP; Brömme D
FEBS Lett; 1997 Apr; 405(3):253-9. PubMed ID: 9108299
[TBL] [Abstract][Full Text] [Related]
19. Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.
Therrien C; Lachance P; Sulea T; Purisima EO; Qi H; Ziomek E; Alvarez-Hernandez A; Roush WR; Ménard R
Biochemistry; 2001 Mar; 40(9):2702-11. PubMed ID: 11258881
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.
van Noort JM; Jacobs MJ
Eur J Immunol; 1994 Sep; 24(9):2175-80. PubMed ID: 8088334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
